These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 29260338)

  • 41. What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?
    Han ES; Monk BJ
    Gynecol Oncol; 2007 Apr; 105(1):3-6. PubMed ID: 17383545
    [No Abstract]   [Full Text] [Related]  

  • 42. Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro.
    Wang Y; Fei D; Vanderlaan M; Song A
    Angiogenesis; 2004; 7(4):335-45. PubMed ID: 15886877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model.
    Jung YD; Mansfield PF; Akagi M; Takeda A; Liu W; Bucana CD; Hicklin DJ; Ellis LM
    Eur J Cancer; 2002 May; 38(8):1133-40. PubMed ID: 12008203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis.
    Urakawa S; Sakai D; Miyazaki Y; Kudo T; Katou A; Inagaki C; Tanaka K; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Satoh T; Mori M; Doki Y
    Surg Case Rep; 2017 Dec; 3(1):127. PubMed ID: 29260338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer.
    Khan U; Shah MA
    Expert Opin Biol Ther; 2019 Nov; 19(11):1135-1141. PubMed ID: 31452409
    [No Abstract]   [Full Text] [Related]  

  • 46. Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Büyükkaramikli NC; Blommestein HM; Riemsma R; Armstrong N; Clay FJ; Ross J; Worthy G; Severens J; Kleijnen J; Al MJ
    Pharmacoeconomics; 2017 Dec; 35(12):1211-1221. PubMed ID: 28656543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ramucirumab: targeting angiogenesis in the treatment of gastric cancer.
    Smyth EC; Tarazona N; Chau I
    Immunotherapy; 2014; 6(11):1177-86. PubMed ID: 25496333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ramucirumab: A Review in Advanced Gastric Cancer.
    Greig SL; Keating GM
    BioDrugs; 2015 Oct; 29(5):341-51. PubMed ID: 26341713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ramucirumab - a new anticancer agent].
    Telekes A; Deme D
    Orv Hetil; 2016 Oct; 157(40):1587-1594. PubMed ID: 27690622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Jejunal perforation secondary to pulmonary mucoepidermoid carcinoma metastasis. Case report and review].
    Moreno-Aguilera E; Galeana-Nogueda FI; Vera-Aguilera J; Vera-Aguilera C; Ley-Marcial LA
    Cir Cir; 2017; 85(3):254-259. PubMed ID: 27260218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ramucirumab for gastric cancer.
    Shitara K; Ohtsu A
    Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):133-9. PubMed ID: 25431958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rectal perforation following paclitaxel and carboplatin chemotherapy for advanced ovarian cancer: a case report and review of the literature.
    Jayakody S; Wright DB; Chiong C; Liu M; Bouffler C; El-Khoury T
    J Med Case Rep; 2018 Aug; 12(1):221. PubMed ID: 30111379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
    Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
    Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Perforation of the small intestine caused by metastasis from primary lung cancer: report of two cases and the discussion of 48 cases published in the Japanese literature].
    Nagashima Y; Okamoto H; Narita Y; Hida N; Naoki K; Kunikane H; Watanabe K
    Nihon Kokyuki Gakkai Zasshi; 2007 May; 45(5):430-5. PubMed ID: 17554989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ramucirumab: A vascular endothelial growth factor receptor-2 inhibitor with activity in several malignancies.
    Grabowski J; Glode A
    Am J Health Syst Pharm; 2016 Jul; 73(13):957-68. PubMed ID: 27217518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma.
    Garrido M
    Expert Rev Anticancer Ther; 2016 Oct; 16(10):1005-10. PubMed ID: 27582051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies.
    Aprile G; Ferrari L; Cremolini C; Bergamo F; Fontanella C; Battaglin F; Rihawi K; Lonardi S; Loupakis F; Scartozzi M
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):877-85. PubMed ID: 27149032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.
    Fujii Y; Hirahara N; Kaji S; Taniura T; Hyakudomi R; Yamamoto T; Tajima Y
    J Med Case Rep; 2018 Mar; 12(1):84. PubMed ID: 29580267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
    Yoshizawa J; Ishizone S; Ikeyama M; Nakayama J
    BMC Cancer; 2017 May; 17(1):368. PubMed ID: 28545511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer.
    Maione P; Sgambato A; Casaluce F; Sacco PC; Santabarbara G; Rossi A; Gridelli C
    Curr Med Chem; 2017; 24(1):3-13. PubMed ID: 27855622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.